Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
P/B ratio for Yakult Honsha Co.,Ltd. (2267.T)
P/B ratio as of 2023: 1.75
According to Yakult Honsha Co.,Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.75. At the end of 2022 the company had a P/B ratio of 3.02.
P/B ratio history for Yakult Honsha Co.,Ltd. from 2004 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 1.75 |
| 2022 | 3.02 |
| 2021 | 2.34 |
| 2020 | 2.22 |
| 2019 | 2.74 |
| 2018 | 3.50 |
| 2017 | 3.58 |
| 2016 | 1.49 |
| 2015 | 1.24 |
| 2014 | 2.13 |
| 2013 | 1.58 |
| 2012 | 1.20 |
| 2011 | 1.07 |
| 2010 | 0.81 |
| 2009 | 0.97 |
| 2008 | 0.73 |
| 2007 | 1.13 |
| 2006 | 1.11 |
| 2005 | 1.12 |
| 2004 | 0.92 |